How original tricuspid valve disease affects new valve lifespan
Part of Heart & circulation clinical trials.
This study looks at how the type of tricuspid valve problem you had originally (narrowing, leaking, or both) might affect how long a replacement valve lasts. If you have had only tricuspid valve replacement surgery, this trial could help doctors understand your long-term outcome better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had surgery to replace only your tricuspid valve (no other heart procedures at the same time).
- You were treated for a narrowed, leaky, or both narrowed and leaky tricuspid valve.
- You have not had any previous heart surgery.
- You are not pregnant or breastfeeding.
- You are not currently in another clinical trial that could affect this one.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the original problem with your aortic valve (narrowing, leaking, or both) might affect how long the replacement valve stays healthy. If you had both your aortic and mitral valves replaced, doctors want to track how well the new valve works over time.
This study looks at people who had their mitral valve replaced to see if the original valve problem (tight vs leaky) affects how long the new valve lasts. It may help doctors understand which patients need closer follow-up.
This trial tests a new catheter-based device to replace your tricuspid valve without open-heart surgery. It's for people with severe tricuspid regurgitation who are at high risk for surgery.
This study tests a new device to fix a leaky tricuspid valve without open-heart surgery. It is for people with severe leakage who are considered too high-risk for traditional surgery.
This trial compares two types of replacement valves for the tricuspid valve: a donated human valve (allograft) and a stented biological valve (made from animal tissue). The goal is to see which works better and lasts longer.
This trial tests whether a new minimally invasive valve replacement device (put through a catheter) can improve health in people with severe right-sided tricuspid valve leaking. It’s for patients who are considered too high-risk for standard open-heart tricuspid surgery.
Hear when a new Degeneration of Tricuspid Surgical Bioprosthesis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.